294 related articles for article (PubMed ID: 34324119)
1. MicroRNAs as biomarkers and perspectives in the therapy of pancreatic cancer.
Xia T; Chen XY; Zhang YN
Mol Cell Biochem; 2021 Dec; 476(12):4191-4203. PubMed ID: 34324119
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
Rawat M; Kadian K; Gupta Y; Kumar A; Chain PSG; Kovbasnjuk O; Kumar S; Parasher G
Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557962
[TBL] [Abstract][Full Text] [Related]
3. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy.
Khan MA; Zubair H; Srivastava SK; Singh S; Singh AP
Adv Exp Med Biol; 2015; 889():71-87. PubMed ID: 26658997
[TBL] [Abstract][Full Text] [Related]
4. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer.
Rachagani S; Macha MA; Heimann N; Seshacharyulu P; Haridas D; Chugh S; Batra SK
Adv Drug Deliv Rev; 2015 Jan; 81():16-33. PubMed ID: 25453266
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of circular RNAs and autophagy-related miRNAs in the diagnosis and treatment of pancreatic cancer.
Jiang PC; Bu SR
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):511-516. PubMed ID: 31610988
[TBL] [Abstract][Full Text] [Related]
6. Targeting miRNAs for pancreatic cancer therapy.
Shi M; Xie D; Gaod Y; Xie K
Curr Pharm Des; 2014; 20(33):5279-86. PubMed ID: 24479803
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs in Pancreatic Cancer: biomarkers, prognostic, and therapeutic modulators.
Daoud AZ; Mulholland EJ; Cole G; McCarthy HO
BMC Cancer; 2019 Nov; 19(1):1130. PubMed ID: 31752758
[TBL] [Abstract][Full Text] [Related]
8. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
9. Developments in miRNA gene signaling pathways in pancreatic cancer.
Vorvis C; Koutsioumpa M; Iliopoulos D
Future Oncol; 2016 May; 12(9):1135-50. PubMed ID: 26984178
[TBL] [Abstract][Full Text] [Related]
10. miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma.
Tesfaye AA; Azmi AS; Philip PA
Am J Pathol; 2019 Jan; 189(1):58-70. PubMed ID: 30558723
[TBL] [Abstract][Full Text] [Related]
11. Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer.
Pal A; Ojha A; Ju J
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139352
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis.
Giulietti M; Occhipinti G; Principato G; Piva F
Cell Oncol (Dordr); 2017 Apr; 40(2):181-192. PubMed ID: 28205147
[TBL] [Abstract][Full Text] [Related]
13. The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer.
He H; Di Y; Liang M; Yang F; Yao L; Hao S; Li J; Jiang Y; Jin C; Fu D
Oncol Rep; 2013 Aug; 30(2):651-8. PubMed ID: 23733161
[TBL] [Abstract][Full Text] [Related]
14. An Integrated Data Analysis of mRNA, miRNA and Signaling Pathways in Pancreatic Cancer.
Sohrabi E; Rezaie E; Heiat M; Sefidi-Heris Y
Biochem Genet; 2021 Oct; 59(5):1326-1358. PubMed ID: 33813720
[TBL] [Abstract][Full Text] [Related]
15. MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer.
Sarwar A; Wang B; Su Q; Zhang Y
Biochem Pharmacol; 2021 Jul; 189():114357. PubMed ID: 33279497
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of fecal microRNAs as novel biomarkers for pancreatic cancer.
Link A; Becker V; Goel A; Wex T; Malfertheiner P
PLoS One; 2012; 7(8):e42933. PubMed ID: 22905187
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as potential therapeutic targets for pancreatic cancer.
Chu X; Wei D; Liu X; Long D; Tian X; Yang Y
Chin Med J (Engl); 2022 Jan; 135(1):4-10. PubMed ID: 34839317
[TBL] [Abstract][Full Text] [Related]
18. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
[TBL] [Abstract][Full Text] [Related]
19. The Roles of MicroRNA in Pancreatic Cancer Progression.
Kt RD; Karthick D; Saravanaraj KS; Jaganathan MK; Ghorai S; Hemdev SP
Cancer Invest; 2022 Sep; 40(8):700-709. PubMed ID: 35333689
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of key microRNAs in pancreatic cancer development.
Baradaran B; Shahbazi R; Khordadmehr M
Biomed Pharmacother; 2019 Jan; 109():1008-1015. PubMed ID: 30551350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
